nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.303	1	CiPCiCtD
Triamcinolone—Prednisone—prostate cancer	0.204	1	CrCtD
Triamcinolone—NR3C1—prostate cancer	0.0651	0.466	CbGaD
Triamcinolone—CYP3A4—prostate cancer	0.0377	0.27	CbGaD
Triamcinolone—PTGS2—prostate cancer	0.0369	0.264	CbGaD
Triamcinolone—Testolactone—Estrone—prostate cancer	0.0246	0.161	CrCrCtD
Triamcinolone—NR3C1—Prednisone—prostate cancer	0.0179	0.17	CbGbCtD
Triamcinolone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0161	0.153	CbGbCtD
Triamcinolone—PTGS2—Etoposide—prostate cancer	0.0096	0.0912	CbGbCtD
Triamcinolone—CYP3A4—Bicalutamide—prostate cancer	0.00845	0.0802	CbGbCtD
Triamcinolone—CYP3A4—Estramustine—prostate cancer	0.00785	0.0746	CbGbCtD
Triamcinolone—CYP3A4—Flutamide—prostate cancer	0.007	0.0665	CbGbCtD
Triamcinolone—CYP3A4—Abiraterone—prostate cancer	0.007	0.0665	CbGbCtD
Triamcinolone—Prednicarbate—Prednisone—prostate cancer	0.00638	0.042	CrCrCtD
Triamcinolone—Testolactone—Prednisone—prostate cancer	0.00638	0.042	CrCrCtD
Triamcinolone—Fluocortolone—Prednisone—prostate cancer	0.0062	0.0408	CrCrCtD
Triamcinolone—Alclometasone—Prednisone—prostate cancer	0.00603	0.0396	CrCrCtD
Triamcinolone—Budesonide—Prednisone—prostate cancer	0.00587	0.0386	CrCrCtD
Triamcinolone—Amcinonide—Prednisone—prostate cancer	0.00587	0.0386	CrCrCtD
Triamcinolone—Diflorasone—Prednisone—prostate cancer	0.00571	0.0376	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisone—prostate cancer	0.00571	0.0376	CrCrCtD
Triamcinolone—Flunisolide—Prednisone—prostate cancer	0.00571	0.0376	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisone—prostate cancer	0.00571	0.0376	CrCrCtD
Triamcinolone—Desonide—Prednisone—prostate cancer	0.00571	0.0376	CrCrCtD
Triamcinolone—Paramethasone—Prednisone—prostate cancer	0.00557	0.0366	CrCrCtD
Triamcinolone—Desoximetasone—Prednisone—prostate cancer	0.00544	0.0357	CrCrCtD
Triamcinolone—Loteprednol—Prednisone—prostate cancer	0.00531	0.0349	CrCrCtD
Triamcinolone—Fluorometholone—Prednisone—prostate cancer	0.00531	0.0349	CrCrCtD
Triamcinolone—Mometasone—Prednisone—prostate cancer	0.00531	0.0349	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00531	0.0349	CrCrCtD
Triamcinolone—Dexamethasone—Prednisone—prostate cancer	0.00519	0.0341	CrCrCtD
Triamcinolone—Betamethasone—Prednisone—prostate cancer	0.00519	0.0341	CrCrCtD
Triamcinolone—Rimexolone—Prednisone—prostate cancer	0.00519	0.0341	CrCrCtD
Triamcinolone—CYP3A4—Cabazitaxel—prostate cancer	0.00518	0.0492	CbGbCtD
Triamcinolone—CYP3A4—Estrone—prostate cancer	0.00506	0.0481	CbGbCtD
Triamcinolone—Methylprednisolone—Prednisone—prostate cancer	0.00496	0.0326	CrCrCtD
Triamcinolone—Prednisolone—Prednisone—prostate cancer	0.00486	0.0319	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisone—prostate cancer	0.00466	0.0306	CrCrCtD
Triamcinolone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00451	0.0428	CbGbCtD
Triamcinolone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00331	0.0314	CbGbCtD
Triamcinolone—CYP3A4—Mitoxantrone—prostate cancer	0.00301	0.0286	CbGbCtD
Triamcinolone—CYP3A4—Estradiol—prostate cancer	0.00291	0.0276	CbGbCtD
Triamcinolone—CYP3A4—Prednisone—prostate cancer	0.0025	0.0237	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—prostate cancer	0.0019	0.018	CbGbCtD
Triamcinolone—CYP3A4—Docetaxel—prostate cancer	0.00174	0.0165	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—prostate cancer	0.00129	0.0123	CbGbCtD
Triamcinolone—NR3C1—urine—prostate cancer	0.000749	0.133	CbGeAlD
Triamcinolone—CYP3A4—urine—prostate cancer	0.000567	0.1	CbGeAlD
Triamcinolone—SERPINA6—renal system—prostate cancer	0.000419	0.0742	CbGeAlD
Triamcinolone—SERPINA6—bone marrow—prostate cancer	0.000317	0.0561	CbGeAlD
Triamcinolone—BCHE—prostate gland—prostate cancer	0.000302	0.0536	CbGeAlD
Triamcinolone—NR3C1—prostate gland—prostate cancer	0.000269	0.0477	CbGeAlD
Triamcinolone—BCHE—seminal vesicle—prostate cancer	0.000256	0.0453	CbGeAlD
Triamcinolone—PTGS2—prostate gland—prostate cancer	0.000233	0.0413	CbGeAlD
Triamcinolone—NR3C1—seminal vesicle—prostate cancer	0.000228	0.0403	CbGeAlD
Triamcinolone—NR3C1—epithelium—prostate cancer	0.000198	0.035	CbGeAlD
Triamcinolone—PTGS2—seminal vesicle—prostate cancer	0.000197	0.0349	CbGeAlD
Triamcinolone—NR3C1—renal system—prostate cancer	0.000183	0.0325	CbGeAlD
Triamcinolone—NR3C1—urethra—prostate cancer	0.00018	0.0319	CbGeAlD
Triamcinolone—PTGS2—epithelium—prostate cancer	0.000171	0.0303	CbGeAlD
Triamcinolone—PTGS2—renal system—prostate cancer	0.000159	0.0281	CbGeAlD
Triamcinolone—PTGS2—urethra—prostate cancer	0.000156	0.0276	CbGeAlD
Triamcinolone—BCHE—bone marrow—prostate cancer	0.000156	0.0276	CbGeAlD
Triamcinolone—CYP3A4—renal system—prostate cancer	0.000139	0.0246	CbGeAlD
Triamcinolone—NR3C1—bone marrow—prostate cancer	0.000139	0.0246	CbGeAlD
Triamcinolone—Amcinonide—ANXA1—prostate cancer	0.000135	0.0722	CrCbGaD
Triamcinolone—BCHE—testis—prostate cancer	0.000133	0.0236	CbGeAlD
Triamcinolone—PTGS2—bone marrow—prostate cancer	0.00012	0.0213	CbGeAlD
Triamcinolone—NR3C1—testis—prostate cancer	0.000119	0.021	CbGeAlD
Triamcinolone—BCHE—lymph node—prostate cancer	9.65e-05	0.0171	CbGeAlD
Triamcinolone—NR3C1—lymph node—prostate cancer	8.59e-05	0.0152	CbGeAlD
Triamcinolone—PTGS2—lymph node—prostate cancer	7.44e-05	0.0132	CbGeAlD
Triamcinolone—Hydrocortisone—ANXA1—prostate cancer	5.71e-05	0.0304	CrCbGaD
Triamcinolone—Testolactone—CYP19A1—prostate cancer	5.45e-05	0.029	CrCbGaD
Triamcinolone—Dexamethasone—CYP3A43—prostate cancer	5.38e-05	0.0287	CrCbGaD
Triamcinolone—Difluprednate—NR3C1—prostate cancer	4.55e-05	0.0243	CrCbGaD
Triamcinolone—Prednicarbate—NR3C1—prostate cancer	4.41e-05	0.0235	CrCbGaD
Triamcinolone—Clocortolone—NR3C1—prostate cancer	4.41e-05	0.0235	CrCbGaD
Triamcinolone—Dexamethasone—ANXA1—prostate cancer	4.25e-05	0.0227	CrCbGaD
Triamcinolone—Desonide—NR3C1—prostate cancer	4.18e-05	0.0223	CrCbGaD
Triamcinolone—Diflorasone—NR3C1—prostate cancer	4.18e-05	0.0223	CrCbGaD
Triamcinolone—Desoximetasone—NR3C1—prostate cancer	4.07e-05	0.0217	CrCbGaD
Triamcinolone—Loteprednol—NR3C1—prostate cancer	4.02e-05	0.0215	CrCbGaD
Triamcinolone—Fludrocortisone—AR—prostate cancer	3.97e-05	0.0212	CrCbGaD
Triamcinolone—Beclomethasone—CYP3A5—prostate cancer	3.81e-05	0.0203	CrCbGaD
Triamcinolone—Fluoxymesterone—SHBG—prostate cancer	3.74e-05	0.0199	CrCbGaD
Triamcinolone—Flumethasone Pivalate—NR3C1—prostate cancer	3.51e-05	0.0187	CrCbGaD
Triamcinolone—Halobetasol Propionate—NR3C1—prostate cancer	3.45e-05	0.0184	CrCbGaD
Triamcinolone—Fluoxymesterone—AR—prostate cancer	3.28e-05	0.0175	CrCbGaD
Triamcinolone—Amcinonide—NR3C1—prostate cancer	3.21e-05	0.0171	CrCbGaD
Triamcinolone—Budesonide—NR3C1—prostate cancer	3.21e-05	0.0171	CrCbGaD
Triamcinolone—Fluticasone furoate—NR3C1—prostate cancer	3.14e-05	0.0168	CrCbGaD
Triamcinolone—Mometasone—NR3C1—prostate cancer	3.05e-05	0.0163	CrCbGaD
Triamcinolone—Rimexolone—NR3C1—prostate cancer	3.02e-05	0.0161	CrCbGaD
Triamcinolone—Fluocinonide—NR3C1—prostate cancer	2.84e-05	0.0152	CrCbGaD
Triamcinolone—Beclomethasone—NR3C1—prostate cancer	2.84e-05	0.0152	CrCbGaD
Triamcinolone—Fluocinolone Acetonide—NR3C1—prostate cancer	2.76e-05	0.0147	CrCbGaD
Triamcinolone—Alclometasone—NR3C1—prostate cancer	2.76e-05	0.0147	CrCbGaD
Triamcinolone—Fludrocortisone—NR3C1—prostate cancer	2.69e-05	0.0143	CrCbGaD
Triamcinolone—Clobetasol propionate—NR3C1—prostate cancer	2.69e-05	0.0143	CrCbGaD
Triamcinolone—Flunisolide—NR3C1—prostate cancer	2.69e-05	0.0143	CrCbGaD
Triamcinolone—Paramethasone—NR3C1—prostate cancer	2.66e-05	0.0142	CrCbGaD
Triamcinolone—Fluorometholone—NR3C1—prostate cancer	2.59e-05	0.0138	CrCbGaD
Triamcinolone—Fluticasone Propionate—CYP3A5—prostate cancer	2.53e-05	0.0135	CrCbGaD
Triamcinolone—Fluoxymesterone—ESR1—prostate cancer	2.52e-05	0.0135	CrCbGaD
Triamcinolone—Methylprednisolone—NR3C1—prostate cancer	2.51e-05	0.0134	CrCbGaD
Triamcinolone—Clobetasol propionate—CYP1A1—prostate cancer	2.44e-05	0.013	CrCbGaD
Triamcinolone—Dexamethasone—CYP17A1—prostate cancer	2.44e-05	0.013	CrCbGaD
Triamcinolone—Prednisolone—CYP2A6—prostate cancer	2.29e-05	0.0122	CrCbGaD
Triamcinolone—Hydrocortisone—SHBG—prostate cancer	2.27e-05	0.0121	CrCbGaD
Triamcinolone—Fluoxymesterone—NR3C1—prostate cancer	2.22e-05	0.0119	CrCbGaD
Triamcinolone—Betamethasone—CYP19A1—prostate cancer	2.14e-05	0.0114	CrCbGaD
Triamcinolone—Asthma—Epirubicin—prostate cancer	2.01e-05	0.000318	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—prostate cancer	2.01e-05	0.000318	CcSEcCtD
Triamcinolone—Back pain—Docetaxel—prostate cancer	2.01e-05	0.000318	CcSEcCtD
Triamcinolone—Tachycardia—Etoposide—prostate cancer	1.99e-05	0.000315	CcSEcCtD
Triamcinolone—Nausea—Goserelin—prostate cancer	1.97e-05	0.000312	CcSEcCtD
Triamcinolone—Hyperhidrosis—Etoposide—prostate cancer	1.97e-05	0.000312	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—prostate cancer	1.97e-05	0.000312	CcSEcCtD
Triamcinolone—Dysgeusia—Capecitabine—prostate cancer	1.97e-05	0.000311	CcSEcCtD
Triamcinolone—Nausea—Conjugated Estrogens—prostate cancer	1.95e-05	0.000309	CcSEcCtD
Triamcinolone—Urticaria—Mitoxantrone—prostate cancer	1.95e-05	0.000308	CcSEcCtD
Triamcinolone—Back pain—Capecitabine—prostate cancer	1.94e-05	0.000307	CcSEcCtD
Triamcinolone—Hypersensitivity—Estradiol—prostate cancer	1.94e-05	0.000306	CcSEcCtD
Triamcinolone—Body temperature increased—Mitoxantrone—prostate cancer	1.94e-05	0.000306	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—prostate cancer	1.93e-05	0.000306	CcSEcCtD
Triamcinolone—Prednisone—NR3C1—prostate cancer	1.92e-05	0.0102	CrCbGaD
Triamcinolone—Muscular weakness—Doxorubicin—prostate cancer	1.9e-05	0.0003	CcSEcCtD
Triamcinolone—Fluticasone Propionate—NR3C1—prostate cancer	1.89e-05	0.0101	CrCbGaD
Triamcinolone—Asthenia—Estradiol—prostate cancer	1.89e-05	0.000298	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—prostate cancer	1.87e-05	0.000296	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—prostate cancer	1.87e-05	0.000295	CcSEcCtD
Triamcinolone—Ill-defined disorder—Capecitabine—prostate cancer	1.86e-05	0.000295	CcSEcCtD
Triamcinolone—Syncope—Docetaxel—prostate cancer	1.86e-05	0.000294	CcSEcCtD
Triamcinolone—Pruritus—Estradiol—prostate cancer	1.86e-05	0.000294	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—prostate cancer	1.86e-05	0.000294	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—prostate cancer	1.86e-05	0.000294	CcSEcCtD
Triamcinolone—Budesonide—CYP3A4—prostate cancer	1.86e-05	0.00991	CrCbGaD
Triamcinolone—Arrhythmia—Prednisone—prostate cancer	1.84e-05	0.000291	CcSEcCtD
Triamcinolone—Paraesthesia—Etoposide—prostate cancer	1.83e-05	0.000289	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—prostate cancer	1.83e-05	0.000289	CcSEcCtD
Triamcinolone—Loss of consciousness—Docetaxel—prostate cancer	1.82e-05	0.000288	CcSEcCtD
Triamcinolone—Fluticasone furoate—CYP3A4—prostate cancer	1.82e-05	0.00972	CrCbGaD
Triamcinolone—Pancreatitis—Doxorubicin—prostate cancer	1.82e-05	0.000288	CcSEcCtD
Triamcinolone—Dyspnoea—Etoposide—prostate cancer	1.82e-05	0.000287	CcSEcCtD
Triamcinolone—Malaise—Capecitabine—prostate cancer	1.81e-05	0.000287	CcSEcCtD
Triamcinolone—Cough—Docetaxel—prostate cancer	1.81e-05	0.000286	CcSEcCtD
Triamcinolone—Hydrocortisone—CYP3A5—prostate cancer	1.81e-05	0.00965	CrCbGaD
Triamcinolone—Vertigo—Capecitabine—prostate cancer	1.81e-05	0.000286	CcSEcCtD
Triamcinolone—Hypersensitivity—Mitoxantrone—prostate cancer	1.81e-05	0.000286	CcSEcCtD
Triamcinolone—Syncope—Capecitabine—prostate cancer	1.8e-05	0.000285	CcSEcCtD
Triamcinolone—Convulsion—Docetaxel—prostate cancer	1.8e-05	0.000284	CcSEcCtD
Triamcinolone—Hypertension—Docetaxel—prostate cancer	1.79e-05	0.000283	CcSEcCtD
Triamcinolone—Erythema—Prednisone—prostate cancer	1.79e-05	0.000283	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—prostate cancer	1.79e-05	0.000283	CcSEcCtD
Triamcinolone—Prednisolone—NR3C1—prostate cancer	1.77e-05	0.00943	CrCbGaD
Triamcinolone—Myalgia—Docetaxel—prostate cancer	1.77e-05	0.000279	CcSEcCtD
Triamcinolone—Loss of consciousness—Capecitabine—prostate cancer	1.77e-05	0.000279	CcSEcCtD
Triamcinolone—Asthenia—Mitoxantrone—prostate cancer	1.76e-05	0.000278	CcSEcCtD
Triamcinolone—Fatigue—Etoposide—prostate cancer	1.76e-05	0.000278	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—prostate cancer	1.76e-05	0.000278	CcSEcCtD
Triamcinolone—Cough—Capecitabine—prostate cancer	1.75e-05	0.000277	CcSEcCtD
Triamcinolone—Prednisone—CYP2C19—prostate cancer	1.75e-05	0.00932	CrCbGaD
Triamcinolone—Pain—Etoposide—prostate cancer	1.74e-05	0.000276	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—prostate cancer	1.74e-05	0.000275	CcSEcCtD
Triamcinolone—Dizziness—Estradiol—prostate cancer	1.74e-05	0.000275	CcSEcCtD
Triamcinolone—Hypertension—Capecitabine—prostate cancer	1.73e-05	0.000274	CcSEcCtD
Triamcinolone—Betamethasone—NR3C1—prostate cancer	1.73e-05	0.00923	CrCbGaD
Triamcinolone—Dry mouth—Docetaxel—prostate cancer	1.73e-05	0.000273	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—prostate cancer	1.73e-05	0.000273	CcSEcCtD
Triamcinolone—Myalgia—Capecitabine—prostate cancer	1.71e-05	0.000271	CcSEcCtD
Triamcinolone—Dexamethasone—CYP1B1—prostate cancer	1.69e-05	0.00903	CrCbGaD
Triamcinolone—Anaphylactic shock—Docetaxel—prostate cancer	1.69e-05	0.000268	CcSEcCtD
Triamcinolone—Oedema—Docetaxel—prostate cancer	1.69e-05	0.000268	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—prostate cancer	1.69e-05	0.000268	CcSEcCtD
Triamcinolone—Discomfort—Capecitabine—prostate cancer	1.69e-05	0.000267	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—prostate cancer	1.69e-05	0.000267	CcSEcCtD
Triamcinolone—Infection—Docetaxel—prostate cancer	1.68e-05	0.000266	CcSEcCtD
Triamcinolone—Feeling abnormal—Etoposide—prostate cancer	1.68e-05	0.000266	CcSEcCtD
Triamcinolone—Dry mouth—Capecitabine—prostate cancer	1.67e-05	0.000265	CcSEcCtD
Triamcinolone—Vomiting—Estradiol—prostate cancer	1.67e-05	0.000264	CcSEcCtD
Triamcinolone—Shock—Docetaxel—prostate cancer	1.67e-05	0.000264	CcSEcCtD
Triamcinolone—Ill-defined disorder—Prednisone—prostate cancer	1.66e-05	0.000263	CcSEcCtD
Triamcinolone—Rash—Estradiol—prostate cancer	1.66e-05	0.000262	CcSEcCtD
Triamcinolone—Dermatitis—Estradiol—prostate cancer	1.66e-05	0.000262	CcSEcCtD
Triamcinolone—Tachycardia—Docetaxel—prostate cancer	1.65e-05	0.000261	CcSEcCtD
Triamcinolone—Headache—Estradiol—prostate cancer	1.65e-05	0.000261	CcSEcCtD
Triamcinolone—Oedema—Capecitabine—prostate cancer	1.64e-05	0.000259	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—prostate cancer	1.64e-05	0.000259	CcSEcCtD
Triamcinolone—Angioedema—Prednisone—prostate cancer	1.64e-05	0.000259	CcSEcCtD
Triamcinolone—Infection—Capecitabine—prostate cancer	1.63e-05	0.000258	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—prostate cancer	1.62e-05	0.000257	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—prostate cancer	1.62e-05	0.000256	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—prostate cancer	1.62e-05	0.000256	CcSEcCtD
Triamcinolone—Malaise—Prednisone—prostate cancer	1.61e-05	0.000255	CcSEcCtD
Triamcinolone—Shock—Capecitabine—prostate cancer	1.61e-05	0.000255	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—prostate cancer	1.61e-05	0.000255	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—prostate cancer	1.61e-05	0.000255	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—prostate cancer	1.61e-05	0.000255	CcSEcCtD
Triamcinolone—Vertigo—Prednisone—prostate cancer	1.61e-05	0.000254	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—prostate cancer	1.61e-05	0.000254	CcSEcCtD
Triamcinolone—Syncope—Prednisone—prostate cancer	1.61e-05	0.000254	CcSEcCtD
Triamcinolone—Alclometasone—CYP3A4—prostate cancer	1.6e-05	0.00854	CrCbGaD
Triamcinolone—Tachycardia—Capecitabine—prostate cancer	1.6e-05	0.000253	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—prostate cancer	1.6e-05	0.000252	CcSEcCtD
Triamcinolone—Hyperhidrosis—Capecitabine—prostate cancer	1.59e-05	0.000251	CcSEcCtD
Triamcinolone—Loss of consciousness—Prednisone—prostate cancer	1.57e-05	0.000249	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—prostate cancer	1.56e-05	0.000247	CcSEcCtD
Triamcinolone—Nausea—Estradiol—prostate cancer	1.56e-05	0.000247	CcSEcCtD
Triamcinolone—Flunisolide—CYP3A4—prostate cancer	1.56e-05	0.00832	CrCbGaD
Triamcinolone—Vomiting—Mitoxantrone—prostate cancer	1.56e-05	0.000246	CcSEcCtD
Triamcinolone—Convulsion—Prednisone—prostate cancer	1.55e-05	0.000245	CcSEcCtD
Triamcinolone—Hypertension—Prednisone—prostate cancer	1.55e-05	0.000244	CcSEcCtD
Triamcinolone—Rash—Mitoxantrone—prostate cancer	1.54e-05	0.000244	CcSEcCtD
Triamcinolone—Dermatitis—Mitoxantrone—prostate cancer	1.54e-05	0.000244	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.54e-05	0.000244	CcSEcCtD
Triamcinolone—Paramethasone—CYP3A4—prostate cancer	1.54e-05	0.00821	CrCbGaD
Triamcinolone—Headache—Mitoxantrone—prostate cancer	1.53e-05	0.000243	CcSEcCtD
Triamcinolone—Insomnia—Docetaxel—prostate cancer	1.53e-05	0.000242	CcSEcCtD
Triamcinolone—Myalgia—Prednisone—prostate cancer	1.52e-05	0.000241	CcSEcCtD
Triamcinolone—Paraesthesia—Docetaxel—prostate cancer	1.52e-05	0.000241	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—prostate cancer	1.51e-05	0.00024	CcSEcCtD
Triamcinolone—Dyspnoea—Docetaxel—prostate cancer	1.51e-05	0.000239	CcSEcCtD
Triamcinolone—Discomfort—Prednisone—prostate cancer	1.51e-05	0.000238	CcSEcCtD
Triamcinolone—Fluorometholone—CYP3A4—prostate cancer	1.5e-05	0.00802	CrCbGaD
Triamcinolone—Hypersensitivity—Etoposide—prostate cancer	1.5e-05	0.000237	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—prostate cancer	1.5e-05	0.000237	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.49e-05	0.000236	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—prostate cancer	1.49e-05	0.000236	CcSEcCtD
Triamcinolone—Dyspepsia—Docetaxel—prostate cancer	1.49e-05	0.000236	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—prostate cancer	1.49e-05	0.000235	CcSEcCtD
Triamcinolone—Insomnia—Capecitabine—prostate cancer	1.48e-05	0.000235	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—prostate cancer	1.48e-05	0.000234	CcSEcCtD
Triamcinolone—Paraesthesia—Capecitabine—prostate cancer	1.47e-05	0.000233	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—prostate cancer	1.46e-05	0.000231	CcSEcCtD
Triamcinolone—Dyspnoea—Capecitabine—prostate cancer	1.46e-05	0.000231	CcSEcCtD
Triamcinolone—Oedema—Prednisone—prostate cancer	1.46e-05	0.000231	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisone—prostate cancer	1.46e-05	0.000231	CcSEcCtD
Triamcinolone—Fatigue—Docetaxel—prostate cancer	1.46e-05	0.000231	CcSEcCtD
Triamcinolone—Nausea—Mitoxantrone—prostate cancer	1.46e-05	0.00023	CcSEcCtD
Triamcinolone—Methylprednisolone—CYP3A4—prostate cancer	1.45e-05	0.00775	CrCbGaD
Triamcinolone—Infection—Prednisone—prostate cancer	1.45e-05	0.00023	CcSEcCtD
Triamcinolone—Pain—Docetaxel—prostate cancer	1.45e-05	0.000229	CcSEcCtD
Triamcinolone—Dyspepsia—Capecitabine—prostate cancer	1.44e-05	0.000228	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—prostate cancer	1.44e-05	0.000228	CcSEcCtD
Triamcinolone—Shock—Prednisone—prostate cancer	1.44e-05	0.000227	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—prostate cancer	1.44e-05	0.000227	CcSEcCtD
Triamcinolone—Tachycardia—Prednisone—prostate cancer	1.43e-05	0.000225	CcSEcCtD
Triamcinolone—Fatigue—Capecitabine—prostate cancer	1.41e-05	0.000224	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisone—prostate cancer	1.41e-05	0.000223	CcSEcCtD
Triamcinolone—Pain—Capecitabine—prostate cancer	1.4e-05	0.000222	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—prostate cancer	1.4e-05	0.000221	CcSEcCtD
Triamcinolone—Feeling abnormal—Docetaxel—prostate cancer	1.4e-05	0.000221	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—prostate cancer	1.37e-05	0.000217	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—prostate cancer	1.35e-05	0.000214	CcSEcCtD
Triamcinolone—Hydrocortisone—NR3C1—prostate cancer	1.35e-05	0.00721	CrCbGaD
Triamcinolone—Feeling abnormal—Capecitabine—prostate cancer	1.35e-05	0.000214	CcSEcCtD
Triamcinolone—Dexamethasone—CYP3A5—prostate cancer	1.35e-05	0.00719	CrCbGaD
Triamcinolone—Dizziness—Etoposide—prostate cancer	1.35e-05	0.000213	CcSEcCtD
Triamcinolone—Body temperature increased—Docetaxel—prostate cancer	1.34e-05	0.000212	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Prednisone—prostate cancer	1.33e-05	0.00021	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—prostate cancer	1.33e-05	0.00021	CcSEcCtD
Triamcinolone—Insomnia—Prednisone—prostate cancer	1.32e-05	0.000209	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisone—prostate cancer	1.31e-05	0.000207	CcSEcCtD
Triamcinolone—Dexamethasone—CYP2A6—prostate cancer	1.31e-05	0.00696	CrCbGaD
Triamcinolone—Urticaria—Capecitabine—prostate cancer	1.3e-05	0.000206	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—prostate cancer	1.3e-05	0.000205	CcSEcCtD
Triamcinolone—Body temperature increased—Capecitabine—prostate cancer	1.3e-05	0.000205	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—prostate cancer	1.3e-05	0.000205	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—prostate cancer	1.3e-05	0.000205	CcSEcCtD
Triamcinolone—Dyspepsia—Prednisone—prostate cancer	1.29e-05	0.000203	CcSEcCtD
Triamcinolone—Rash—Etoposide—prostate cancer	1.29e-05	0.000203	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—prostate cancer	1.28e-05	0.000203	CcSEcCtD
Triamcinolone—Headache—Etoposide—prostate cancer	1.28e-05	0.000202	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—prostate cancer	1.27e-05	0.000201	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—prostate cancer	1.26e-05	0.0002	CcSEcCtD
Triamcinolone—Fatigue—Prednisone—prostate cancer	1.26e-05	0.000199	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—prostate cancer	1.26e-05	0.000199	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—prostate cancer	1.26e-05	0.000199	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—prostate cancer	1.25e-05	0.000198	CcSEcCtD
Triamcinolone—Hypersensitivity—Docetaxel—prostate cancer	1.25e-05	0.000197	CcSEcCtD
Triamcinolone—Dexamethasone—CYP19A1—prostate cancer	1.24e-05	0.00663	CrCbGaD
Triamcinolone—Loss of consciousness—Epirubicin—prostate cancer	1.23e-05	0.000195	CcSEcCtD
Triamcinolone—Cough—Epirubicin—prostate cancer	1.22e-05	0.000193	CcSEcCtD
Triamcinolone—Asthenia—Docetaxel—prostate cancer	1.22e-05	0.000192	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—prostate cancer	1.21e-05	0.000192	CcSEcCtD
Triamcinolone—Nausea—Etoposide—prostate cancer	1.21e-05	0.000191	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—prostate cancer	1.21e-05	0.000191	CcSEcCtD
Triamcinolone—Hypersensitivity—Capecitabine—prostate cancer	1.21e-05	0.000191	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisone—prostate cancer	1.2e-05	0.00019	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—prostate cancer	1.2e-05	0.00019	CcSEcCtD
Triamcinolone—Pruritus—Docetaxel—prostate cancer	1.2e-05	0.00019	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—prostate cancer	1.19e-05	0.000188	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—prostate cancer	1.18e-05	0.000186	CcSEcCtD
Triamcinolone—Asthenia—Capecitabine—prostate cancer	1.18e-05	0.000186	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—prostate cancer	1.17e-05	0.000185	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—prostate cancer	1.17e-05	0.000184	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Triamcinolone—Urticaria—Prednisone—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Triamcinolone—Pruritus—Capecitabine—prostate cancer	1.16e-05	0.000184	CcSEcCtD
Triamcinolone—Body temperature increased—Prednisone—prostate cancer	1.15e-05	0.000183	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—prostate cancer	1.14e-05	0.000181	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—prostate cancer	1.14e-05	0.000181	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—prostate cancer	1.14e-05	0.00018	CcSEcCtD
Triamcinolone—Infection—Epirubicin—prostate cancer	1.13e-05	0.00018	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—prostate cancer	1.13e-05	0.000179	CcSEcCtD
Triamcinolone—Shock—Epirubicin—prostate cancer	1.12e-05	0.000178	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—prostate cancer	1.12e-05	0.000177	CcSEcCtD
Triamcinolone—Dizziness—Docetaxel—prostate cancer	1.12e-05	0.000177	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—prostate cancer	1.12e-05	0.000177	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—prostate cancer	1.11e-05	0.000176	CcSEcCtD
Triamcinolone—Prednisone—CYP3A4—prostate cancer	1.11e-05	0.00593	CrCbGaD
Triamcinolone—Hyperhidrosis—Epirubicin—prostate cancer	1.1e-05	0.000175	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—prostate cancer	1.1e-05	0.000174	CcSEcCtD
Triamcinolone—Fluticasone Propionate—CYP3A4—prostate cancer	1.1e-05	0.00584	CrCbGaD
Triamcinolone—Discomfort—Doxorubicin—prostate cancer	1.09e-05	0.000172	CcSEcCtD
Triamcinolone—Dizziness—Capecitabine—prostate cancer	1.08e-05	0.000172	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—prostate cancer	1.08e-05	0.000171	CcSEcCtD
Triamcinolone—Vomiting—Docetaxel—prostate cancer	1.08e-05	0.00017	CcSEcCtD
Triamcinolone—Hypersensitivity—Prednisone—prostate cancer	1.08e-05	0.00017	CcSEcCtD
Triamcinolone—Rash—Docetaxel—prostate cancer	1.07e-05	0.000169	CcSEcCtD
Triamcinolone—Dermatitis—Docetaxel—prostate cancer	1.07e-05	0.000169	CcSEcCtD
Triamcinolone—Headache—Docetaxel—prostate cancer	1.06e-05	0.000168	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—prostate cancer	1.06e-05	0.000167	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—prostate cancer	1.06e-05	0.000167	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—prostate cancer	1.05e-05	0.000166	CcSEcCtD
Triamcinolone—Asthenia—Prednisone—prostate cancer	1.05e-05	0.000166	CcSEcCtD
Triamcinolone—Vomiting—Capecitabine—prostate cancer	1.04e-05	0.000165	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.04e-05	0.000165	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—prostate cancer	1.04e-05	0.000164	CcSEcCtD
Triamcinolone—Rash—Capecitabine—prostate cancer	1.03e-05	0.000164	CcSEcCtD
Triamcinolone—Pruritus—Prednisone—prostate cancer	1.03e-05	0.000163	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—prostate cancer	1.03e-05	0.000163	CcSEcCtD
Triamcinolone—Dermatitis—Capecitabine—prostate cancer	1.03e-05	0.000163	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—prostate cancer	1.03e-05	0.000163	CcSEcCtD
Triamcinolone—Headache—Capecitabine—prostate cancer	1.03e-05	0.000162	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—prostate cancer	1.03e-05	0.000162	CcSEcCtD
Triamcinolone—Prednisolone—CYP3A4—prostate cancer	1.02e-05	0.00546	CrCbGaD
Triamcinolone—Hyperhidrosis—Doxorubicin—prostate cancer	1.02e-05	0.000162	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—prostate cancer	1.02e-05	0.000161	CcSEcCtD
Triamcinolone—Dexamethasone—NR3C1—prostate cancer	1.01e-05	0.00537	CrCbGaD
Triamcinolone—Nausea—Docetaxel—prostate cancer	1.01e-05	0.000159	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—prostate cancer	1.01e-05	0.000159	CcSEcCtD
Triamcinolone—Betamethasone—CYP3A4—prostate cancer	1e-05	0.00535	CrCbGaD
Triamcinolone—Fatigue—Epirubicin—prostate cancer	9.85e-06	0.000156	CcSEcCtD
Triamcinolone—Betamethasone—PTGS2—prostate cancer	9.83e-06	0.00524	CrCbGaD
Triamcinolone—Pain—Epirubicin—prostate cancer	9.77e-06	0.000155	CcSEcCtD
Triamcinolone—Nausea—Capecitabine—prostate cancer	9.74e-06	0.000154	CcSEcCtD
Triamcinolone—Dizziness—Prednisone—prostate cancer	9.66e-06	0.000153	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.63e-06	0.000152	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—prostate cancer	9.56e-06	0.000151	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—prostate cancer	9.49e-06	0.00015	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—prostate cancer	9.42e-06	0.000149	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—prostate cancer	9.41e-06	0.000149	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—prostate cancer	9.3e-06	0.000147	CcSEcCtD
Triamcinolone—Vomiting—Prednisone—prostate cancer	9.29e-06	0.000147	CcSEcCtD
Triamcinolone—Dexamethasone—CYP2E1—prostate cancer	9.27e-06	0.00494	CrCbGaD
Triamcinolone—Rash—Prednisone—prostate cancer	9.21e-06	0.000146	CcSEcCtD
Triamcinolone—Dermatitis—Prednisone—prostate cancer	9.2e-06	0.000146	CcSEcCtD
Triamcinolone—Dexamethasone—CYP2C19—prostate cancer	9.18e-06	0.0049	CrCbGaD
Triamcinolone—Headache—Prednisone—prostate cancer	9.15e-06	0.000145	CcSEcCtD
Triamcinolone—Dexamethasone—CYP1A1—prostate cancer	9.15e-06	0.00488	CrCbGaD
Triamcinolone—Fatigue—Doxorubicin—prostate cancer	9.11e-06	0.000144	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—prostate cancer	9.08e-06	0.000144	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—prostate cancer	9.04e-06	0.000143	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—prostate cancer	9.03e-06	0.000143	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—prostate cancer	8.71e-06	0.000138	CcSEcCtD
Triamcinolone—Nausea—Prednisone—prostate cancer	8.68e-06	0.000137	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—prostate cancer	8.42e-06	0.000133	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—prostate cancer	8.4e-06	0.000133	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—prostate cancer	8.36e-06	0.000132	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—prostate cancer	8.2e-06	0.00013	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—prostate cancer	8.08e-06	0.000128	CcSEcCtD
Triamcinolone—Hydrocortisone—CYP3A4—prostate cancer	7.84e-06	0.00418	CrCbGaD
Triamcinolone—Hypersensitivity—Doxorubicin—prostate cancer	7.79e-06	0.000123	CcSEcCtD
Triamcinolone—Asthenia—Doxorubicin—prostate cancer	7.58e-06	0.00012	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—prostate cancer	7.55e-06	0.000119	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—prostate cancer	7.48e-06	0.000118	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—prostate cancer	7.26e-06	0.000115	CcSEcCtD
Triamcinolone—Rash—Epirubicin—prostate cancer	7.2e-06	0.000114	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—prostate cancer	7.2e-06	0.000114	CcSEcCtD
Triamcinolone—Headache—Epirubicin—prostate cancer	7.16e-06	0.000113	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—prostate cancer	6.99e-06	0.000111	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—prostate cancer	6.79e-06	0.000107	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—prostate cancer	6.72e-06	0.000106	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—prostate cancer	6.67e-06	0.000105	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—prostate cancer	6.66e-06	0.000105	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—prostate cancer	6.62e-06	0.000105	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—prostate cancer	6.28e-06	9.93e-05	CcSEcCtD
Triamcinolone—Dexamethasone—CYP3A4—prostate cancer	5.84e-06	0.00311	CrCbGaD
Triamcinolone—Dexamethasone—PTGS2—prostate cancer	5.72e-06	0.00305	CrCbGaD
Triamcinolone—PTGS2—Metabolism—SLC22A1—prostate cancer	3.79e-06	0.000147	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP3A4—prostate cancer	3.79e-06	0.000147	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.77e-06	0.000146	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—B2M—prostate cancer	3.75e-06	0.000146	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFBR1—prostate cancer	3.75e-06	0.000146	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.75e-06	0.000146	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1B1—prostate cancer	3.72e-06	0.000145	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UGT2B15—prostate cancer	3.71e-06	0.000144	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UGT2B17—prostate cancer	3.71e-06	0.000144	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GRHPR—prostate cancer	3.71e-06	0.000144	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CKMT2—prostate cancer	3.71e-06	0.000144	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SULT2A1—prostate cancer	3.7e-06	0.000144	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.69e-06	0.000144	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKR1C3—prostate cancer	3.69e-06	0.000143	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPS19—prostate cancer	3.69e-06	0.000143	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKACB—prostate cancer	3.67e-06	0.000143	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MED12—prostate cancer	3.64e-06	0.000141	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SIRT1—prostate cancer	3.62e-06	0.000141	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GNG5—prostate cancer	3.61e-06	0.00014	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GGT1—prostate cancer	3.6e-06	0.00014	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPP3CA—prostate cancer	3.58e-06	0.000139	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—VDR—prostate cancer	3.57e-06	0.000139	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NCOA1—prostate cancer	3.55e-06	0.000138	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP19A1—prostate cancer	3.5e-06	0.000136	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SULT2B1—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AOX1—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MBTPS1—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PGAM2—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM3—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RFK—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAGLU—prostate cancer	3.49e-06	0.000135	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOA3—prostate cancer	3.47e-06	0.000135	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCZ—prostate cancer	3.46e-06	0.000135	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.41e-06	0.000133	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CALR—prostate cancer	3.4e-06	0.000132	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—RXRA—prostate cancer	3.38e-06	0.000131	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PARP1—prostate cancer	3.34e-06	0.00013	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGFR4—prostate cancer	3.34e-06	0.00013	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HPGDS—prostate cancer	3.31e-06	0.000129	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AMACR—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—DEGS1—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAT1—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CALCA—prostate cancer	3.3e-06	0.000128	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2C19—prostate cancer	3.29e-06	0.000128	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.28e-06	0.000128	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ERCC2—prostate cancer	3.27e-06	0.000127	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—COMT—prostate cancer	3.25e-06	0.000126	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTP1—prostate cancer	3.24e-06	0.000126	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTT1—prostate cancer	3.21e-06	0.000125	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ACHE—prostate cancer	3.21e-06	0.000125	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ITPR1—prostate cancer	3.19e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2A6—prostate cancer	3.18e-06	0.000123	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HSPA1A—prostate cancer	3.17e-06	0.000123	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.17e-06	0.000123	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—prostate cancer	3.16e-06	0.000123	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.15e-06	0.000123	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.13e-06	0.000122	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.12e-06	0.000121	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKR1C3—prostate cancer	3.09e-06	0.00012	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PRKACB—prostate cancer	3.07e-06	0.000119	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP17A1—prostate cancer	3.04e-06	0.000118	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CASP9—prostate cancer	3.04e-06	0.000118	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARA—prostate cancer	3.01e-06	0.000117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TYMS—prostate cancer	3.01e-06	0.000117	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3e-06	0.000117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—prostate cancer	2.97e-06	0.000116	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	2.95e-06	0.000115	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCQ—prostate cancer	2.94e-06	0.000114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPL—prostate cancer	2.92e-06	0.000113	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	2.91e-06	0.000113	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOA2—prostate cancer	2.9e-06	0.000113	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1A1—prostate cancer	2.82e-06	0.00011	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—B4GALT4—prostate cancer	2.81e-06	0.000109	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HPGD—prostate cancer	2.81e-06	0.000109	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF10—prostate cancer	2.8e-06	0.000109	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ERCC2—prostate cancer	2.8e-06	0.000109	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A5—prostate cancer	2.77e-06	0.000107	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—prostate cancer	2.73e-06	0.000106	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2E1—prostate cancer	2.7e-06	0.000105	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NQO1—prostate cancer	2.67e-06	0.000104	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFBR2—prostate cancer	2.66e-06	0.000103	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.64e-06	0.000103	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TH—prostate cancer	2.63e-06	0.000102	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—prostate cancer	2.63e-06	0.000102	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ITPR1—prostate cancer	2.62e-06	0.000102	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.62e-06	0.000102	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP3A4—prostate cancer	2.61e-06	0.000101	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARA—prostate cancer	2.58e-06	0.0001	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.57e-06	9.99e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTAP—prostate cancer	2.57e-06	9.99e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1B1—prostate cancer	2.56e-06	9.95e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.5e-06	9.73e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.5e-06	9.73e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GGT1—prostate cancer	2.48e-06	9.64e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOA1—prostate cancer	2.44e-06	9.5e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAV1—prostate cancer	2.43e-06	9.42e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP19A1—prostate cancer	2.41e-06	9.36e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LPL—prostate cancer	2.4e-06	9.33e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CREBBP—prostate cancer	2.39e-06	9.3e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.39e-06	9.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACSL4—prostate cancer	2.39e-06	9.28e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFRB—prostate cancer	2.38e-06	9.24e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—RXRA—prostate cancer	2.32e-06	9.03e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.32e-06	9e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERCC2—prostate cancer	2.3e-06	8.93e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PHGDH—prostate cancer	2.29e-06	8.9e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UMPS—prostate cancer	2.29e-06	8.9e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ARG2—prostate cancer	2.29e-06	8.9e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.26e-06	8.78e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB3—prostate cancer	2.25e-06	8.74e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LDHB—prostate cancer	2.25e-06	8.73e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGFR2—prostate cancer	2.24e-06	8.72e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.24e-06	8.72e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—COMT—prostate cancer	2.24e-06	8.7e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—prostate cancer	2.23e-06	8.66e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—prostate cancer	2.21e-06	8.58e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.2e-06	8.57e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ITPR1—prostate cancer	2.19e-06	8.52e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—prostate cancer	2.16e-06	8.4e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.16e-06	8.38e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—prostate cancer	2.15e-06	8.37e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PDHA1—prostate cancer	2.13e-06	8.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TCN2—prostate cancer	2.13e-06	8.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA3—prostate cancer	2.13e-06	8.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UCP3—prostate cancer	2.13e-06	8.28e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INS—prostate cancer	2.09e-06	8.13e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TYMS—prostate cancer	2.07e-06	8.05e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIF1A—prostate cancer	2.06e-06	8.01e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CREBBP—prostate cancer	2.05e-06	7.96e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—prostate cancer	2.05e-06	7.96e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.03e-06	7.89e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.03e-06	7.89e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPL—prostate cancer	2.01e-06	7.81e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CAV1—prostate cancer	1.99e-06	7.75e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA4—prostate cancer	1.95e-06	7.57e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.95e-06	7.57e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—prostate cancer	1.94e-06	7.55e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1A1—prostate cancer	1.94e-06	7.54e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ERCC2—prostate cancer	1.93e-06	7.48e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA2—prostate cancer	1.9e-06	7.38e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG5—prostate cancer	1.87e-06	7.29e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.87e-06	7.29e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BAD—prostate cancer	1.87e-06	7.28e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NOS3—prostate cancer	1.83e-06	7.13e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTA1—prostate cancer	1.83e-06	7.12e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APC—prostate cancer	1.82e-06	7.06e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTO1—prostate cancer	1.81e-06	7.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.81e-06	7.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NAT2—prostate cancer	1.81e-06	7.04e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—prostate cancer	1.81e-06	7.03e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGF—prostate cancer	1.79e-06	6.97e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IRS1—prostate cancer	1.79e-06	6.97e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARA—prostate cancer	1.78e-06	6.9e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GSK3B—prostate cancer	1.74e-06	6.77e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLCB2—prostate cancer	1.74e-06	6.75e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.74e-06	6.75e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LRP2—prostate cancer	1.74e-06	6.75e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—INS—prostate cancer	1.72e-06	6.68e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—P4HB—prostate cancer	1.7e-06	6.62e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—prostate cancer	1.69e-06	6.58e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CREBBP—prostate cancer	1.68e-06	6.54e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—prostate cancer	1.68e-06	6.52e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAV1—prostate cancer	1.67e-06	6.49e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.66e-06	6.44e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.61e-06	6.27e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAP2K1—prostate cancer	1.61e-06	6.24e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—prostate cancer	1.6e-06	6.2e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.59e-06	6.2e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MED12—prostate cancer	1.59e-06	6.17e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SERPINE1—prostate cancer	1.58e-06	6.13e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GNG5—prostate cancer	1.58e-06	6.12e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF2—prostate cancer	1.53e-06	5.94e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—prostate cancer	1.52e-06	5.91e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.52e-06	5.9e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS3—prostate cancer	1.51e-06	5.86e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAK2—prostate cancer	1.46e-06	5.69e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—prostate cancer	1.46e-06	5.68e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.45e-06	5.63e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INS—prostate cancer	1.44e-06	5.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.44e-06	5.59e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MDM2—prostate cancer	1.43e-06	5.56e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—prostate cancer	1.42e-06	5.52e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CREBBP—prostate cancer	1.41e-06	5.48e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB2—prostate cancer	1.41e-06	5.48e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.4e-06	5.46e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACHE—prostate cancer	1.4e-06	5.46e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—EP300—prostate cancer	1.39e-06	5.42e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—prostate cancer	1.39e-06	5.41e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.39e-06	5.39e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.35e-06	5.25e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.34e-06	5.22e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—prostate cancer	1.34e-06	5.19e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.33e-06	5.16e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1B—prostate cancer	1.31e-06	5.07e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.27e-06	4.92e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NOS3—prostate cancer	1.26e-06	4.9e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—prostate cancer	1.23e-06	4.79e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.21e-06	4.69e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1A—prostate cancer	1.2e-06	4.68e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—prostate cancer	1.2e-06	4.67e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.18e-06	4.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NQO1—prostate cancer	1.17e-06	4.53e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—prostate cancer	1.17e-06	4.53e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TH—prostate cancer	1.15e-06	4.47e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EP300—prostate cancer	1.15e-06	4.46e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.12e-06	4.35e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SRC—prostate cancer	1.11e-06	4.33e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GGT1—prostate cancer	1.08e-06	4.21e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—prostate cancer	1.08e-06	4.18e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.07e-06	4.15e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.05e-06	4.09e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—prostate cancer	1.03e-06	4.01e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—RXRA—prostate cancer	1.02e-06	3.94e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—prostate cancer	1.01e-06	3.91e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—prostate cancer	9.99e-07	3.88e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—prostate cancer	9.97e-07	3.87e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—prostate cancer	9.85e-07	3.83e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—COMT—prostate cancer	9.78e-07	3.8e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGFR—prostate cancer	9.77e-07	3.8e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—prostate cancer	9.73e-07	3.78e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—EP300—prostate cancer	9.6e-07	3.73e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ITPR1—prostate cancer	9.58e-07	3.72e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—prostate cancer	9.23e-07	3.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TYMS—prostate cancer	9.05e-07	3.52e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—prostate cancer	8.94e-07	3.48e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPL—prostate cancer	8.78e-07	3.41e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—prostate cancer	8.48e-07	3.3e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1A1—prostate cancer	8.48e-07	3.29e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—prostate cancer	8.43e-07	3.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ERCC2—prostate cancer	8.41e-07	3.27e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—prostate cancer	7.9e-07	3.07e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARA—prostate cancer	7.75e-07	3.01e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—prostate cancer	7.51e-07	2.92e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAV1—prostate cancer	7.29e-07	2.83e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—prostate cancer	7.1e-07	2.76e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—prostate cancer	6.93e-07	2.69e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—prostate cancer	6.64e-07	2.58e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INS—prostate cancer	6.29e-07	2.44e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CREBBP—prostate cancer	6.16e-07	2.39e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.84e-07	2.27e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—prostate cancer	5.8e-07	2.25e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NOS3—prostate cancer	5.51e-07	2.14e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.09e-07	1.98e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—prostate cancer	5.04e-07	1.96e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—prostate cancer	4.4e-07	1.71e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—EP300—prostate cancer	4.19e-07	1.63e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.1e-07	1.21e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—prostate cancer	2.53e-07	9.85e-06	CbGpPWpGaD
